Why It Matters
Cook Group Inc., the Bloomington-based medical device manufacturer, spent $120,000 on federal lobbying in the second quarter of 2026.
Cook Group operates as an in-house lobbying registrant, relying on its Vice President of Global Government Affairs, Allison Giles, to manage federal relations.
By the Numbers
Cook Group's lobbying disclosure filings over the past year reveal a consistent approach to federal advocacy. The company spent $120,000 each in the second, third, and fourth quarters of 2025, before jumping to $200,000 in the first quarter of 2026. The second quarter filing brought spending back to $120,000, generating $680,000 in total lobbying revenue across five filings over the past year.
Broader Context
The company has previously lobbied on Medicare coverage of breakthrough technologies and supplies incident to physician services. Cook Group also advocated for the American Innovation and Jobs Act, which would expand the refundable research and development tax credit for startups and new businesses.
The company expressed support for the legislation, citing that the U.S. ranks 28th among OECD nations in tax incentive support for research and development. The bill, introduced by Sen. Todd Young (R-IN) and Sen. Maggie Hassan (D-NH), would restore immediate deductions for research and development investments that expired at the end of 2021.
The Bottom Line
Cook Group's second quarter lobbying activity reflects the company's steady engagement with federal policymakers on healthcare and tax issues. The return to baseline spending after a spike in the first quarter suggests a normalized pace of federal advocacy, even as the company adjusts its lobbying infrastructure.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article